• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇在风湿性多肌痛中的应用——不同治疗方案综述

Corticosteroids in polymyalgia rheumatica--a review of different treatment schedules.

作者信息

Li C, Dasgupta B

机构信息

Department of Rheumatology, Southend Hospital, Westcliff-on-Sea, Essex, UK.

出版信息

Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S56-7.

PMID:10948765
Abstract

Low dose oral steroids (prednisolone 10-15 mg daily) are currently advocated for the treatment of uncomplicated PMR and the dose should be carefully adjusted in relation to disease activity. Intramuscular methylprednisolone has been shown to have a similar remission rate to oral steroids and a better side effect profile with respect to fracture rate and weight gain. Prophylaxis for osteoporosis at least with calcium and vitamin D should be initiated at the start of steroid therapy.

摘要

目前提倡使用低剂量口服类固醇(每日泼尼松龙10 - 15毫克)治疗无并发症的巨细胞动脉炎,且应根据疾病活动情况仔细调整剂量。已表明肌内注射甲泼尼龙与口服类固醇的缓解率相似,在骨折率和体重增加方面副作用更小。类固醇治疗开始时应至少使用钙和维生素D进行骨质疏松症预防。

相似文献

1
Corticosteroids in polymyalgia rheumatica--a review of different treatment schedules.皮质类固醇在风湿性多肌痛中的应用——不同治疗方案综述
Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S56-7.
2
Treatment of polymyalgia rheumatica with intramuscular injections of depot methylprednisolone.肌肉注射长效甲基强的松龙治疗风湿性多肌痛。
Ann Rheum Dis. 1991 Dec;50(12):942-5. doi: 10.1136/ard.50.12.942.
3
An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica.一项为期96周的双盲对照试验,比较长效甲基强的松龙与口服强的松龙治疗风湿性多肌痛的疗效。
Br J Rheumatol. 1998 Feb;37(2):189-95. doi: 10.1093/rheumatology/37.2.189.
4
Concise guidance: diagnosis and management of polymyalgia rheumatica.简明指南:巨细胞动脉炎的诊断与管理。
Clin Med (Lond). 2010 Jun;10(3):270-4. doi: 10.7861/clinmedicine.10-3-270.
5
Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.地夫可特与甲泼尼龙治疗风湿性多肌痛的比较:不同治疗方案的临床等效性及相对抗炎效力
J Rheumatol. 1995 Aug;22(8):1492-8.
6
Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.目前关于巨细胞动脉炎治疗干预和预后因素的证据:一项系统文献回顾,为 2015 年欧洲抗风湿病联盟/美国风湿病学会巨细胞动脉炎管理建议提供信息。
Ann Rheum Dis. 2015 Oct;74(10):1808-17. doi: 10.1136/annrheumdis-2015-207578.
7
Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica.风湿性多肌痛的观点与未满足的需求。为风湿性多肌痛新治疗方案的开发提供基本框架。
Reumatismo. 2018 Mar 27;70(1):1-9. doi: 10.4081/reumatismo.2018.1070.
8
[Treatment and diagnosis of polymyalgia rheumatica and temporal arteritis].[风湿性多肌痛和颞动脉炎的治疗与诊断]
Tidsskr Nor Laegeforen. 2003 Dec 4;123(23):3387.
9
Medical management of polymyalgia rheumatica.巨细胞动脉炎的医学治疗。
Expert Opin Pharmacother. 2010 May;11(7):1077-87. doi: 10.1517/14656561003724739.
10
Glucocorticoid treatment of polymyalgia rheumatica.糖皮质激素治疗巨细胞动脉炎。
Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S143-7. Epub 2011 Oct 22.

引用本文的文献

1
Rates of glucocorticoid taper in the management of polymyalgia rheumatica: the science behind the "art".风湿性多肌痛管理中糖皮质激素减量的速率:“艺术”背后的科学
Clin Rheumatol. 2025 Jan;44(1):105-113. doi: 10.1007/s10067-024-07248-0. Epub 2024 Dec 6.
2
Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab.托珠单抗治疗的巨细胞动脉炎患者的超声和磁共振成像变化。
Arthritis Res Ther. 2018 Jan 25;20(1):11. doi: 10.1186/s13075-017-1499-2.
3
The role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysis.
生物制剂在大血管血管炎(LVV)治疗中的作用:一项系统评价和荟萃分析。
PLoS One. 2014 Dec 17;9(12):e115026. doi: 10.1371/journal.pone.0115026. eCollection 2014.
4
Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica.勃艮第风湿病学家的专业实践研究:巨细胞动脉炎的初始皮质激素治疗。
Clin Rheumatol. 2011 Jan;30(1):51-6. doi: 10.1007/s10067-010-1619-8. Epub 2010 Nov 18.
5
Best practice in primary care pathology: review 2.基层医疗病理学的最佳实践:综述2
J Clin Pathol. 2006 Feb;59(2):113-20. doi: 10.1136/jcp.2005.031526.
6
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology.糖皮质激素剂量和糖皮质激素治疗方案的标准化命名法:风湿病学中的当前问题及初步答案
Ann Rheum Dis. 2002 Aug;61(8):718-22. doi: 10.1136/ard.61.8.718.
7
Polymyalgia rheumatica/temporal arteritis: recent advances.风湿性多肌痛/颞动脉炎:最新进展
Curr Rheumatol Rep. 2002 Feb;4(1):39-46. doi: 10.1007/s11926-002-0022-0.